IRIS
DE PALMA, Raffaele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 33
AS - Asia 9
NA - Nord America 5
Totale 47
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 17
IE - Irlanda 13
US - Stati Uniti d'America 5
VN - Vietnam 4
IN - India 2
SG - Singapore 2
CN - Cina 1
CZ - Repubblica Ceca 1
FR - Francia 1
RU - Federazione Russa 1
Totale 47
Salva come PNG Salva come JPEG
Città #
Dublin 13
Caserta 6
Dong Ket 4
Naples 4
Marano Di Napoli 2
Ashburn 1
Bengaluru 1
Caivano 1
Council Bluffs 1
Houston 1
Jaipur 1
Saint Petersburg 1
Wuhan 1
Totale 37
Salva come PNG Salva come JPEG
Nome #
Intratracheal administration of mesenchymal stem cells modulates tachykinin system, suppresses airway remodeling and reduces airway hyperresponsiveness in an animal model, file dfd1c04a-fd44-0799-e053-6605fe0a8ddb 12
Upregulation of TH/IL-17 Pathway-Related Genes in Human Coronary Endothelial Cells Stimulated with Serum of Patients with Acute Coronary Syndromes, file dfd1c04b-7974-0799-e053-6605fe0a8ddb 7
Chitinase 3-like-1 is produced by human Th17 cells and correlates with the level of inflammation in juvenile idiopathic arthritis patients, file dfd1c04b-5bf5-0799-e053-6605fe0a8ddb 6
Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells, file dfd1c04d-3444-0799-e053-6605fe0a8ddb 3
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors, file dfd1c04a-6036-0799-e053-6605fe0a8ddb 2
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines, file dfd1c04a-60a4-0799-e053-6605fe0a8ddb 2
Immune-inflammatory activation in acute coronary syndromes: A look into the heart of unstable coronary plaque, file dfd1c04b-af83-0799-e053-6605fe0a8ddb 2
Eomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammation., file dfd1c04c-4456-0799-e053-6605fe0a8ddb 2
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy., file dfd1c04c-76c3-0799-e053-6605fe0a8ddb 2
Sphingosine-1-phosphate/sphingosine kinase pathway is involved in mouse airway hyperresponsiveness., file dfd1c04a-2380-0799-e053-6605fe0a8ddb 1
C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation, file dfd1c04a-3b42-0799-e053-6605fe0a8ddb 1
Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients, file dfd1c04a-4271-0799-e053-6605fe0a8ddb 1
Use of antagonist peptides to inhibit in vitro T cell responses to Par j1, the major allergen of Parietaria judaica pollen, file dfd1c04a-5010-0799-e053-6605fe0a8ddb 1
Th1/Th2 lymphocyte polarization in asthma, file dfd1c04a-51be-0799-e053-6605fe0a8ddb 1
Perianal Crohn's disease and hidradenitis suppurativa: a possible common immunological scenario, file dfd1c04a-7b82-0799-e053-6605fe0a8ddb 1
Pregnancy-associated plasma protein-A promotes TF procoagulant activity in human endothelial cells by Akt–NF-κB axis, file dfd1c04b-07a6-0799-e053-6605fe0a8ddb 1
Human circulating group 2 innate lymphoid cells can express CD154 and promote IgE production, file dfd1c04b-8b04-0799-e053-6605fe0a8ddb 1
Uso e preparazione di glicolipidi come adiuvanti in vaccini, Brevetto US Patent 20,160,151,483, 2016, file dfd1c04b-9785-0799-e053-6605fe0a8ddb 1
Sphingosine Kinases promote IL-17 expression in human T lymphocytes., file dfd1c04c-2c2e-0799-e053-6605fe0a8ddb 1
Totale 48
Salva come PNG Salva come JPEG
Categoria #
all - tutte 361
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 361
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192 0 0 0 0 0 0 0 0 0 0 2 0
2019/20205 0 0 0 1 0 0 1 0 0 0 2 1
2020/20215 0 0 0 0 1 0 0 0 0 0 0 4
2021/20221 0 0 0 0 0 0 1 0 0 0 0 0
2022/202325 0 4 1 1 0 2 0 0 15 1 1 0
2023/20241 0 0 0 0 0 0 0 0 0 1 0 0
Totale 48